|

MT-304 + Nivolumab Clinical Trials

1 actively recruiting trial

Also known as: mRNA-LNP

Pipeline

Phase 1: 1

Top Sponsors

  • Myeloid Therapeutics1

Indications

  • HER2-Expressing Solid Tumors1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.